GALMED PHARMACEUTICALS LTD. Increase (Decrease) in Accounts and Other Receivables
GALMED PHARMACEUTICALS LTD. (GLMD) reported Increase (Decrease) in Accounts and Other Receivables of -$107.00 thousand for the 6-month period ending 2026-06-30, per its 6-K filed 2026-09-02.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables · last filed 2026-09-02
- GALMED PHARMACEUTICALS LTD. increase (decrease) in accounts and other receivables for the quarter ending 2025-12-31 was -$117.00K, a 147.56% decline year-over-year.
- GALMED PHARMACEUTICALS LTD. increase (decrease) in accounts and other receivables for the quarter ending 2025-09-30 was $116.00K, a 60.14% decline year-over-year.
- GALMED PHARMACEUTICALS LTD. increase (decrease) in accounts and other receivables for the quarter ending 2024-12-31 was $246.00K.
- GALMED PHARMACEUTICALS LTD. increase (decrease) in accounts and other receivables for the quarter ending 2024-09-30 was $291.00K.
| Period end | Increase (Decrease) in Accounts and Other Receivables 3 month | Increase (Decrease) in Accounts and Other Receivables 6 month | Increase (Decrease) in Accounts and Other Receivables 9 month | Increase (Decrease) in Accounts and Other Receivables 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$107.00K 6-K · filed 2026-09-02 | |||
| 2025-12-31 | -$117.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-31 | -$1.00K derived: sum of 2 quarters · filed 2026-03-31 | -$240.00K 20-F · filed 2026-03-31 | |
| 2025-09-30 | $116.00K derived: 6-K 9 month − 6-K 6 month · filed 2025-11-26 | -$123.00K 6-K · filed 2025-11-26 | ||
| 2025-06-30 | -$239.00K 6-K · filed 2026-09-02 | |||
| 2024-12-31 | $246.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-31 | $537.00K derived: sum of 2 quarters · filed 2026-03-31 | $192.00K 20-F · filed 2026-03-31 | |
| 2024-09-30 | $291.00K derived: 6-K 9 month − 6-K 6 month · filed 2025-11-26 | -$54.00K 6-K · filed 2025-11-26 | ||
| 2024-06-30 | -$345.00K 6-K · filed 2025-08-28 | |||
| 2023-12-31 | -$345.00K 20-F · filed 2026-03-31 | |||
| 2023-06-30 | -$484.00K 6-K · filed 2024-08-28 | |||
| 2022-12-31 | -$300.00K 20-F · filed 2025-04-02 | |||
| 2022-06-30 | -$511.00K 6-K · filed 2023-08-09 | |||
| 2021-12-31 | $313.00K 20-F · filed 2024-04-04 | |||
| 2021-06-30 | -$325.00K 6-K · filed 2022-08-04 | |||
| 2020-12-31 | -$15.00K 20-F · filed 2023-03-29 | |||
| 2020-06-30 | -$158.00K 6-K · filed 2021-08-05 | |||
| 2019-12-31 | $609.00K 20-F · filed 2022-05-02 | |||
| 2019-06-30 | $487.00K 6-K · filed 2020-08-06 | |||
| 2018-12-31 | $63.00K 20-F · filed 2021-03-18 | |||
| 2018-06-30 | $213.00K 6-K · filed 2019-08-05 | |||
| 2017-12-31 | -$129.00K 20-F · filed 2020-03-12 | |||
| 2017-06-30 | -$18.00K 6-K · filed 2018-08-02 | |||
| 2016-12-31 | -$95.00K 20-F · filed 2019-03-13 | |||
| 2016-06-30 | -$43.00K 6-K · filed 2017-07-31 | |||
| 2015-12-31 | $214.00K 20-F · filed 2018-03-13 | |||
| 2015-06-30 | $220.00K 6-K · filed 2017-06-23 | |||
| 2014-12-31 | $149.00K 20-F · filed 2017-03-23 | |||
| 2013-12-31 | $2.00K 20-F · filed 2016-03-22 | |||
| 2012-12-31 | $11.00K 20-F · filed 2015-03-31 |